Evidence map›Paper›PMID 41293647›Full record

ArticleJournal of inflammation research2025

PCK2, a SASP-Associated Gene, Serves as an Independent Prognostic Indicator in Diffuse Large B-Cell Lymphoma.

Minggui Chen, Yueyuan Pan, Jinfang Zhang, Yan Zeng

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Minggui Chen *Department of Precision Clinical Laboratory, Zhanjiang Central Hospital, Guangdong Medical University (Central People's Hospital of Zhanjiang), Zhanjiang, Guangdong, 524023, People's Republic of China.
Yueyuan Pan *Zhanjiang Institute of Clinical Medicine, Zhanjiang Central Hospital, Guangdong Medical University (Central People's Hospital of Zhanjiang), Zhanjiang, Guangdong, 524023, People's Republic of China.
Jinfang ZhangDepartment of Pathology, Shenzhen Nanshan People's Hospital (NSPH), Shenzhen, Guangdong, 518052, People's Republic of China.
Yan ZengDepartment of Precision Clinical Laboratory, Zhanjiang Central Hospital, Guangdong Medical University (Central People's Hospital of Zhanjiang), Zhanjiang, Guangdong, 524023, People's Republic of China.ORCID 0000-0002-9823-1266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diffuse large B-cell lymphoma (DLBCL) is characterised by substantial heterogeneity in phenotype and genetics. Recent studies have demonstrated that senescence-associated secretory phenotype (SASP) is both a tumor suppressor and a promoter of tumorigenesis and progression. However, reports on the effects of SASP on DLBCL remain limited. This study aimed to identify the SASP-related indicator of DLBCL, thereby providing new insights into the pathology of DLBCL. Methods: Differential analysis and weighted co-expression network analysis (WGCNA) were applied to identify differentially expressed genes (DEGs) and key gene modules of DLBCL. Univariate Cox regression analysis was employed to identify SASP-related genes that serve as independent risk factors for DLBCL prognosis. Overlapped among three methods to obtain the hub gene and explore its potential mechanisms in DLBCL. The association between Results: In this study, through integrated bioinformatics methods, Conclusion: As a SASP-related gene,

Indexed as

DLBCLGlycolysisPCK2SASPTumor immune microenvironment

Identifiers

PMID41293647
PMCPMC12642796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.